APA (7th ed.) Citation

Fang, X., Border, J. J., Zhang, H., Challagundla, L., Kaur, J., Hwang, S. H., . . . Roman, R. J. (2025). A Soluble Epoxide Hydrolase Inhibitor Improves Cerebrovascular Dysfunction, Neuroinflammation, Amyloid Burden, and Cognitive Impairments in the hAPP/PS1 TgF344-AD Rat Model of Alzheimer's Disease. International Journal of Molecular Sciences, 26(6), 2433. https://doi.org/10.3390/ijms26062433

Chicago Style (17th ed.) Citation

Fang, Xing, Jane J. Border, Huawei Zhang, Lavanya Challagundla, Jasleen Kaur, Sung Hee Hwang, Bruce D. Hammock, Fan Fan, and Richard J. Roman. "A Soluble Epoxide Hydrolase Inhibitor Improves Cerebrovascular Dysfunction, Neuroinflammation, Amyloid Burden, and Cognitive Impairments in the HAPP/PS1 TgF344-AD Rat Model of Alzheimer's Disease." International Journal of Molecular Sciences 26, no. 6 (2025): 2433. https://doi.org/10.3390/ijms26062433.

MLA (9th ed.) Citation

Fang, Xing, et al. "A Soluble Epoxide Hydrolase Inhibitor Improves Cerebrovascular Dysfunction, Neuroinflammation, Amyloid Burden, and Cognitive Impairments in the HAPP/PS1 TgF344-AD Rat Model of Alzheimer's Disease." International Journal of Molecular Sciences, vol. 26, no. 6, 2025, p. 2433, https://doi.org/10.3390/ijms26062433.